全文获取类型
收费全文 | 2259篇 |
免费 | 173篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 67篇 |
妇产科学 | 83篇 |
基础医学 | 432篇 |
口腔科学 | 18篇 |
临床医学 | 190篇 |
内科学 | 452篇 |
皮肤病学 | 55篇 |
神经病学 | 259篇 |
特种医学 | 79篇 |
外国民族医学 | 5篇 |
外科学 | 257篇 |
综合类 | 4篇 |
预防医学 | 134篇 |
眼科学 | 18篇 |
药学 | 138篇 |
中国医学 | 11篇 |
肿瘤学 | 210篇 |
出版年
2023年 | 12篇 |
2022年 | 17篇 |
2021年 | 28篇 |
2020年 | 22篇 |
2019年 | 53篇 |
2018年 | 46篇 |
2017年 | 44篇 |
2016年 | 40篇 |
2015年 | 63篇 |
2014年 | 83篇 |
2013年 | 93篇 |
2012年 | 187篇 |
2011年 | 131篇 |
2010年 | 100篇 |
2009年 | 67篇 |
2008年 | 137篇 |
2007年 | 149篇 |
2006年 | 129篇 |
2005年 | 156篇 |
2004年 | 148篇 |
2003年 | 145篇 |
2002年 | 128篇 |
2001年 | 44篇 |
2000年 | 45篇 |
1999年 | 38篇 |
1998年 | 26篇 |
1997年 | 24篇 |
1996年 | 17篇 |
1995年 | 14篇 |
1994年 | 19篇 |
1993年 | 16篇 |
1992年 | 21篇 |
1991年 | 17篇 |
1990年 | 17篇 |
1989年 | 6篇 |
1988年 | 16篇 |
1987年 | 11篇 |
1985年 | 8篇 |
1984年 | 8篇 |
1983年 | 7篇 |
1978年 | 8篇 |
1975年 | 5篇 |
1974年 | 11篇 |
1973年 | 6篇 |
1972年 | 6篇 |
1971年 | 7篇 |
1970年 | 5篇 |
1969年 | 7篇 |
1967年 | 5篇 |
1966年 | 6篇 |
排序方式: 共有2439条查询结果,搜索用时 15 毫秒
101.
Odile Basso Jean-Fran?ois Lascourreges Fran?ois Le Borgne Cyril Le Goff Michel Magot 《Research in microbiology》2009,160(2):107-116
The bacterial diversity of a subsurface water sample collected from a gas storage aquifer in an Upper Jurassic calcareous formation was investigated by culture of microorganisms and construction of a 16S rRNA gene library. Both culture and molecular techniques showed that members of the phyla Firmicutes and class δ-proteobacteria dominated the bacterial community. The presence of hydrogen-utilizing autotrophic bacteria including sulfate reducers (e.g. Desulfovibrio aespoeensis) and homoacetogens (e.g. Acetobacterium carbinolicum) suggested that CO2 and H2 are the main carbon and energy sources sustaining a nutrient-limited subsurface lithoautotrophic microbial ecosystem (SLiME). Gram-positive SRB belonging to the genus Desulfotomaculum, frequently observed in subsurface environments, represented 25% of the clone library and 4 distinct phylotypes. No Archaea were detected by both experimental approaches.Water samples were collected in an area of the rauracian geological formation located outside the maximum seasonal extension of underground gas storage. Considering the observed microbial diversity, there is no evidence of any influence on the microbial ecology of the aquifer in the surroundings of maximum extension reached by the gas bubble of the underground storage, which should have resulted from the introduction of exogenous carbon and energy sources in a nutrient-limited ecosystem. 相似文献
102.
103.
104.
At cellular level, signalization pathway activated by ErbB receptors participate to the proliferation, migration and differenciation of many cellular types. Observed alterations are mutations, overexpressions with or without gene amplification or abnormal stimulation by their ligands. The most frequently observed mutation is an extracellular deletion aiming to activate tyrosine kinase activity without ligand. Strategies to target the EGFr receptor include antisens oligonucleotids, antibodies directed to extracellular component of tyrosine kinase receptor. Only monoclonal antibodies and TKI have been developed in clinical research, mainly for oesophageal and rectal carcinomas. Solid tumor proliferation is under control of tumoral mechanisms and the interaction between tumor and microenvironment. In particular, angiogenesis is important during invasive and metastasis phases. The major role of Vasculoendothelial Growth Factor (VEGF) in angiogenesis is useful for tumor growth, which has been demonstrated by many convergent studies. Radiosensitivation or reversion of radioresistance could be obtained by inhibition of VEGF pathway. Antibodies directed against this molecule have been introduced in GI tract malignancies for the treatment of pancreatic and colic carcinomas. 相似文献
105.
Ludivine Bissler Khadija Chahraoui Thierry Altwegg Marie-Christine Bône-Lépinoy Giles Truc Giles Créhange 《Psycho-Oncologie》2007,1(4):241-245
Taboos related to cancer, ageing and sexuality are still topical and challenge sexuality for prostate cancer patients. Analysis of interviews with patients highlights the changes caused by the disease and treatments and the significance that they have on sexual life. Doctors must therefore focus on quality of life for these men whose masculinity is deeply affected. 相似文献
106.
107.
Marie‐Odile Carrre Nora Moumjid‐Ferdjaoui Marie Charavel Alain Brmond 《Health expectations》2000,3(2):97-113
Introduction
In developed countries, the physician‐patient relationship is moving from a paternalistic model to new decision‐making models that take patient preferences into account.Objectives
Our aim was to develop a Decision Board (DB) and to test its acceptability in a French Regional Cancer Centre regarding the decision on whether or not to use chemotherapy after surgery in postmenopausal women with breast cancer. This paper presents the development process for this instrument and reports the pretesting phase, as well as the corresponding results.Methods
A working group was created with oncologists, psychologists and economists. Following the first phase, i.e. the development process, a first version of the instrument was presented to health professionals. Their feedback led to important modifications of the instrument. The DB was then presented to experienced patients, which resulted in slight changes. The second phase consisted of pretesting the comprehension, internal and across‐time consistency of the DB on healthy volunteers.Results
The DB was pretested in a group of 40 healthy volunteers. Eighteen respondents chose chemotherapy and 22 chose not to have chemotherapy. Comprehension rates were very high (≥87.5%). Internal consistency was assessed considering option attitudes based on outcomes and option attitudes based on process. Women shifted their choices in a predictable way. Across‐time consistency was appraised using the test‐retest method with Visual Analog Scales. The Intraclass Correlation Coefficient was 0.97.Discussion‐conclusion
Due to cultural differences, the DB developed in our French Cancer Centre is quite different from the DBs previously developed elsewhere. Our instrument showed good comprehension and consistency properties, which are corroborated by the DB literature. Whether our DB is acceptable for patients with breast cancer must still be tested. Patients’ reactions will tell us which type of decision‐making model is at work. Further research is needed in order to explore the shared decision‐making process and clarify the concept.108.
Martin S Lĵo H Peuskens J Thirumalai S Giudicelli A Fleurot O Rein W;SOLIANOL Study Group 《Current medical research and opinion》2002,18(6):355-362
OBJECTIVE: To compare the efficacy and safety of the atypical antipsychotics amisulpride and olanzapine in the treatment of acute psychotic exacerbations of schizophrenia. DESIGN AND SETTING: A multinational, double-blind randomised clinical trial. PATIENTS AND TREATMENT: Three hundred and seventy-seven patients with predominantly positive symptomatology were treated for six months with either amisulpride (200-800 mg/d) or olanzapine (5-20 mg/d). MAIN OUTCOME MEASURES: Short-term results were analysed after two months of treatment. The primary efficacy measure was the change of score on the Brief Psychiatric Rating Scale (BPRS). Other measures of efficacy and safety were also evaluated. RESULTS: Psychotic symptoms, as measured on the BPRS score, improved with both treatments, amisulpride being equivalent to olanzapine. All BPRS factor scores, as well as depressive symptoms, improved to a similar extent with both treatments. Less than five per cent of patients withdrew for adverse events, and there was no evidence for the emergence of extrapyramidal symptoms with either treatment. Statistically significant greater weight gain (2.7 +/- 3.9 kg) was observed during the study in the olanzapine group, compared with the amisulpride group (0.9 +/- 3.2 kg, p < 0.0001). CONCLUSIONS: Amisulpride and olanzapine show equivalent efficacy at 2 months in the treatment of acute psychotic exacerbations of schizophrenia. Amisulpride offers a significant advantage in preserving body weight. 相似文献
109.
Brouri F Findji L Mediani O Mougenot N Hanoun N Le Naour G Hamon M Lechat P 《European journal of pharmacology》2002,439(1-3):69-75
This study investigates the effect of microinjections of capsaicin in the periaqueductal grey matter of rats on nociceptive behaviour and the possible interactions with NMDA and mGlu receptors. Intra-periaqueductal grey microinjection of capsaicin (1-3-6 nmol/rat) increased the latency of the nociceptive reaction in the plantar test. This effect was prevented by pretreatment with capsazepine (6 nmol/rat), which had no effect per se on the latency of the nociceptive reaction. 7-(Hydroxyimino)cyclopropa[b]chromen-1alpha-carboxylate ethyl ester (CPCCOEt, 50 nmol/rat) and 2-Methyl-6-(phenylethynyl)pyridine (MPEP, 50 nmol/rat), antagonists of mGlu(1) and mGlu(5) receptors, respectively, completely blocked the effect of capsaicin. Similarly, pretreatment with DL-2-Amino-5-phosphonovaleric acid (DL-AP5, 5 nmol/rat) and riluzole (4 nmol/rat), an NMDA receptor antagonist and a voltage-dependent Na(+) channels blocker which inhibits glutamate release, respectively, completely antagonized the effect of capsaicin. However, pretreatment with (2S)-alpha-Ethylglutamic acid (30 nmol/rat) and (RS)-alpha-Methylserine-O-phosphate (MSOP, 30 nmol/rat), antagonists of group II and group III mGlu receptors, respectively, had no effects on capsaicin-induced analgesia. Similarly, pretreatment with N-(piperidin-1-yl)-5-(4-chlophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR 141716A, 5 pmol/rat), a selective cannabinoid CB(1) receptor antagonist, did not affect the capsaicin-induced antinociception. In conclusion, this study shows that capsaicin might produce antinociception at the periaqueductal grey level by increasing glutamate release, which activates postsynaptic group I mGlu and NMDA receptors. 相似文献
110.
Suzan F Guasch G Terre C Garcia I Bastie JN Maarek O Ribaud P Gluckman E Daniel MT Pébusque MJ Castaigne S 《British journal of haematology》2003,121(2):312-314
A rare atypical myeloproliferative disorder (aMPD) associated with chromosomal translocations involving the short arm of chromosome 8, region p11-p12 has been described. In most patients, the cytogenetic abnormality is a t(8;13)(p12;q12) that fuses fibroblast growth factor receptor 1, the 8p12 key gene, to FIM/ZNF198 gene. Prognosis is poor with frequent evolution to acute myeloid leukaemia within 1 year of diagnosis. We report a new patient with aMPD with a t(8;13) translocation. Complete haematological, cytogenetic and molecular remission was demonstrated 39 months after allogeneic bone marrow transplantation. This is the first report to demonstrate a molecular remission in this disorder. 相似文献